BioMed Central advocates full and transparent reporting. Please ensure that your paper provides the information requested below where applicable. On submitting your paper you will be asked to confirm you have included this information, or give reasons for any instances where it is not made available. You will also be asked to upload this file and it should be cited in the Methods section.
Experimental design and statistics
The following information should be included in the Methods section and inserted in the table below:
Question Answer 1. The exact sample size (n) for each experimental group/condition (as a number, not a range). Include details of a power analysis if done, or any other relevant considerations that determined the choice of sample size. For n < 6, individual data values should be shown rather than summary statistics alone. 2. A description of sample collection that enables the reader to understand whether the samples represent technical or biological replicates, and an explanation of inclusion/exclusion criteria if samples or organisms were excluded from the analysis. 3. How samples/ organisms were allocated to experimental groups and processed, and full details of the randomisation procedure used (if relevant). 4. For sample assessment by human investigators, a statement on whether the investigator was blinded to group assignment and outcome assessment, and how this blinding was achieved and evaluated (if relevant).
A total of 276 people were recruited, including 215 FD patients and 61 healthy control group (HC)., individual data values we have list in Table 1 .
Before the samples were collected, all participants were fasted for 12 hours but were allowed to drink water to avoid the effects of food on the final outcome. Blood from both the healthy control groupand spleen deficiency groupwere sampled via the antecubital vein, from which 5mL was collected into heparinized test tubes and centrifuged at 3000 rpm for 15min at 4•C to separate the supernatant, and the supernatant was centrifuged at 3500 rpm for 8min at 4•C, and the supernatant obtained at the end served as the plasma sample. The plasma samples were collected and stored at −80•C for the metabonomic analysis.
Irrelevant
Irrelevant 5. How many times each experiment shown was replicated and an indication of the extent of variation from experiment to experiment. 6. Information on the statistical methods and measures used. It should be clear whether the tests are one-sided or two-sided, whether there are adjustments for multiple comparisons, whether medians or means are being shown, whether error bars are standard deviations (SD), standard error of mean (SEM) or confidence intervals. 7. A justification for the appropriateness of statistical tests used to assess significance. Do the data meet the assumptions of the tests? Is there an estimate of variation within each group of data, and is the variance similar between groups that are being statistically compared? In addition, information essential to interpreting the data presented should be made available in the figure and table legends. If the study involves health interventions for human participants, please refer to the relevant reporting guidelines from the EQUATOR Network, and the Biosharing Portal for reporting checklists for biological and biomedical research, where applicable.
Research involving humans
If your research involved humans, please confirm you have adhered to the relevant reporting guideline from the EQUATOR Network, and included the completed checklist as an additional file with your submission:
Answer (page and line number inserted/Not applicable for my study) -I have followed the relevant reporting for my study type, and included a populated checklist with my submission -Not applicable for my study
The experimental data were obtained from 3 independent and parallel tests.
The results are expressed as mean ± standard error (SEM). Continuous variables were described as the mean ± SD and compared by the independent sample t-test. Categorical variables were recorded as percentages and analyzed using the Chi-square testy applying SPSS19.0. Two-sided P values <0.05 were considered statistically significant. Metabolite with variable importance plot (VIP) > 1 was screened as a potential biomarker.
The data is consistent with the assumptions of the test. In addition, we estimated the variation of each set of data, and the results were similar to the differences between the groups that were statistically compared. This study was approved by the by the Ethical Review Committee of Xiyuan Hospital of China Academy of Chinese Medical Sciences 2013XL013-2). All enrolled patients were confirmed to have signed informed consent after enrollment.
Resources
A description of all resources used should be included in the Methods section, with enough information to allow them to be uniquely identified. The table below should be completed with confirmation that this was done (i.e. included in the Methods section) or is not applicable. If this has not been completed, but is applicable, you should contact the journal editorial staff before proceeding.
Answer (page and line number inserted/Not applicable for my study)
•Antibodies: report source, catalogue code, characteristics, dilutions and how they were validated for the system under study.
•Cell lines: report source, whether identity has been authenticated and whether tested for mycoplasma contamination. We encourage researchers to check the NCBI database for contamination of cell lines.
•Organisms: report source, species, strain, sex, age, husbandry, inbred and strain characteristics of transgenic and mutant animals.
•Tools (software, databases and services): report standard tool name, provider and version number, if available. For antibodies, model organisms (mice, zebrafish and flies) and tools, authors are strongly encouraged to cite Research Resource Identifiers (RRIDs). To do so, please go to the Resource Identification Portal to search for your research resource and insert the reference text into your Methods section. 
